Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

926
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
926
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

6.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.1K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

5.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
5.2K
Analgesia and Pain Management01:25

Analgesia and Pain Management

2.8K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.8K
The Two-State Receptor Model01:29

The Two-State Receptor Model

3.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.4K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

4.6K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Double dissociation in the involvement of noradrenergic and endocannabinoid systems in classical and higher-order conditioning in newborn rabbits.

Neurobiology of learning and memory·2026
Same author

Astrocytic mGluR5 Regulation of Synaptic Transmission is Activity-Dependent in Adult Rats.

Glia·2026
Same author

Locus coeruleus α-synuclein overexpression induces prodromal Parkinsonian features in mice.

NPJ Parkinson's disease·2026
Same author

Review: "The Disappointment Dilemma: Short- and Long-Term Learning From Negative Outcomes".

The European journal of neuroscience·2026
Same author

Mitochondrial Calcium Signaling in the Brain: From Molecular Mechanisms to Behavioral Outcomes.

The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry·2026
Same author

Multiple bursting patterns in lateral habenula neurons: Experiments and computational model.

The Journal of physiology·2026
Same journal

Exploring potential strategies to enhance memory and cognition in aging mice.

F1000Research·2026
Same journal

Construction an Implicit Block Multi-Steps Approach for Solving Sixth-Order Fractional Differential Equations.

F1000Research·2026
Same journal

Kansei Engineering in the Evolving Service Sector: A Decade of Insights.

F1000Research·2026
Same journal

A Safety-First Mindset:  Role of Patient Safety Culture in Enhancing Healthcare Workers' Emotional Intelligence.

F1000Research·2026
Same journal

Decoding Decisions: Personality-Interest Motivational Sequences as Predictors of Career Paths.

F1000Research·2026
Same journal

Beyond the Transparent Barrier: A Domain Visualization and Integrative Review of Contemporary Research on Gender-Based Professional Stasis.

F1000Research·2026
See all related articles

Related Experiment Video

Updated: Mar 20, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

651

Cannabinoid receptor type-1: breaking the dogmas.

Arnau Busquets Garcia1, Edgar Soria-Gomez1, Luigi Bellocchio1

  • 1Endocannabinoids and Neuroadaptation, INSERM U1215 NeuroCentre Magendie, Bordeaux, 33077, France; University of Bordeaux, Bordeaux, France.

F1000Research
|May 31, 2016
PubMed
Summary
This summary is machine-generated.

The endocannabinoid system (ECS) regulates many brain functions via cannabinoid receptors, particularly CB1. New research reveals CB1 receptor

Keywords:
CB1 receptor signalingEndocannabinoid systemallosteric modulatorcannabinoid ligandsmolecular pharmacology

More Related Videos

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

3.0K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K

Related Experiment Videos

Last Updated: Mar 20, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

651
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

3.0K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • The endocannabinoid system (ECS) is crucial for regulating numerous physiological functions.
  • The ECS comprises cannabinoid receptors, endogenous ligands (endocannabinoids), and metabolic enzymes.

Purpose of the Study:

  • To review recent advancements in cannabinoid signaling, focusing on the type-1 cannabinoid receptor (CB1).
  • To explore the diverse cellular and subcellular localization of CB1 receptors and their functional implications.
  • To discuss the potential of CB1 receptor modulation for therapeutic applications.

Main Methods:

  • Review of recent literature on cannabinoid signaling and CB1 receptor research.
  • Analysis of studies utilizing novel imaging and molecular tools to investigate CB1 receptor distribution.
  • Examination of research on CB1 receptor structure and allosteric modulation.

Main Results:

  • CB1 receptors are found in various cell types (neuronal, glial) and intracellular compartments (mitochondria).
  • CB1 receptor function is dependent on its specific cellular and subcellular localization, influencing distinct cellular effects.
  • CB1 receptors are present in the periphery, modulating brain-periphery communication.
  • New understanding of CB1 receptor structure has led to the development of novel allosteric modulators.

Conclusions:

  • Recent advances provide a deeper understanding of CB1 receptor biology and signaling.
  • The diverse localization and function of CB1 receptors offer significant therapeutic potential.
  • Further research into CB1 receptor modulators could lead to improved therapeutic strategies.